The North America generic injectables market is witnessing strong expansion, driven by rising demand for cost-effective therapies, increasing chronic disease burden, and a well-established healthcare infrastructure. The region, led by the United States, holds a dominant share in the global market due to high adoption of generics and favorable regulatory frameworks that encourage competition.
In...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek